Prognosis Omicron’s Spread Across Hotel Hall Highlights Transmission Worry The omicron variant spread among two fully vaccinated travelers across the hallway of a Hong Kong quarantine hotel, underscoring why the highly mutated coronavirus strain is unnerving health authorities. Closed-circuit television camera footage showed neither person left their room nor had any contact, leaving airborne transmission when respective doors were opened for food collection or Covid testing the most probable mode of spread, researchers at the University of Hong Kong said in a study published Friday in the journal Emerging Infectious Diseases. Geat irony here in Hong Kong they knock on your hotel door daily to test you and this looks like the spread event-
They are going to have to grovel to china I hate that. I just saw the newish movie with the ten rings... Shang- Chi It was pretty good. fight scenes are dope.
Diversity Check. This is a tough one. That lower right spot (their left) why always there? Holding the phone in front of the face... it could mean anything. Lets call this a " C+ "
<< THE AFTERNOON RAP >> Cloopen rises 18.9% » 10:00 RAAS-? Cloopen On my Chin. No. Rekor Systems participates in a conference call with Northland 13:53 REKR Conference call with management will be held on December 15 at 3 pm hosted by Northland. Canaccord remains bullish on Adicet after 'highly positive' interim ADI-001 data 10:29 ACET Canaccord analyst John Newman notes that Adicet Bio's ADI-001, an allogeneic gamma delta CAR T cell therapy, demonstrated overall response rate of 75% and complete response rate of 50% in n=4 efficacy evaluable patients, with 2/3 responses at the lowest dose level. ADI-001's safety profile was "encouraging," with no dose-limiting toxicities, graft versus host disease, immune effector cell-associated neurotoxicity syndrome or grade 3 or higher cytokine release syndrome, Newman adds, pointing out that more dosing cohorts are expected to be added, with additional data the first half of 2022. The analyst maintains a Buy rating and $28 price target on the shares, based on positive Phase 1 data for ADI-001 in non-Hodgkin's lymphoma. He believes gamma delta T-cells have unique properties that could minimize rejection and help overcome immunosuppression in both hematologic malignancies and solid tumors. ACET + 30% Google announces Quick Tap to Snap feature for Pixel phones 13:10 GOOGL, GOOG, SNAP Sherry Lin, Product Manager at Google (GOOGL), announced in a blog post: "One of the sweet things about being a Pixel user is that your phone continues to get a boost of helpfulness with Feature Drops. Whether you want to quickly tap to access Snapchat from your Pixel lock screen or control the bass levels on your Pixel Buds A-Series, we've got an update you'll love. This latest Feature Drop will roll out to users over the next few weeks, starting today with relevant updates coming to Pixel 3a through Pixel 5a (5G) devices... Pixel 6 and Pixel 6 Pro devices will begin receiving their updates next week... You can already customize the actions your Pixel takes when you use Quick Tap, from taking a screenshot to playing music. With Quick Tap to Snap, you can access Snapchat directly from your lock screen, making Pixel the fastest phone to make a Snap. Quick Tap to Snap is available to all Pixel 4a with 5G or newer Pixel phones. Plus, starting this month, you'll be able to add a new Pixel-exclusive Lens - Pixel Face - to your Snaps." Blink Charging, SG Blocks announce expanded charging station deal 10:33 BLNK, SGBX Blink Charging (BLNK) and SG Blocks (SGBX) announced to collaborate for the deployment of Blink's EV charging equipment and network via SG Blocks' modular designs. The new agreement expands the original 2020 Master Development and Production Agreement, executed between SG Blocks and Blink, to include SGDC, SG Blocks' real estate subsidiary. SGDC expects to use Blink's electric vehicle charging equipment, network, technology, and know-how in all current and future development sites, elevating the amenities offered at each location and enabling each resident the opportunity to reduce their carbon footprint, the companies said in a statement. Fastly 'stands by' revenue guidance, says pricing pressure declined in 2021 13:32 FSLY "We're happy with how the quarter is progressing and we stand by our existing revenue guidance. Today, a big part of our business is usage-based and there will always be some inherent volatility and our revenue guidance will continue to reflect that inherent volatility in our business and the outlook we have high confidence in. [...] We actually saw a deceleration of pricing pressure in 2021. Pricing declines in '21 were actually lower than what we saw in '19 and '20," Ron Kisling, CFO of Fastly, said during the Raymond James Technology Investors Conference. B. Riley bullish on Novavax, Agenus amid Omicron spread 10:57 NVAX, AGEN, VXRT B. Riley analyst Mayank… Novartis at work on pan-coronavirus oral treatment, Reuters reports 12:05 NVS Novartis is working on a pill that could work broadly against coronaviruses, not just the one that causes COVID-19, CEO Vas Narasimhan told Reuters, Pushkala Aripaka reports. In an interview following his recent presentation at Total Health last week, Narasimhan said that "I think we as a sector have collaborated extremely well to ultimately be the industry that enabled this pandemic over time to eventually be under control." HealthEquity options imply 8.6% move in share price post-earnings 14:04 HQY Pre-earnings options volume in HealthEquity is 4.5x normal with puts leading calls 8:5. Implied volatility suggests the market is anticipating a move near 8.6%, or $4.82, after results are released. Median move over the past eight quarters is 4.6%. HQY $56.41<------- + 3.6%<------ 5% left..... OUR STOCK OF THE DAY TOOK OFF! CI&T Inc. (CINT) NYSE - Nasdaq Real Time 13.51+1.16(+9.39%)<------------- As of 02:32PM EST. Market open.
It closed at $85.50 GTLB Stoney!!! $84 ah's ... buy it!!!! Watch this one tomorrow. Low float high short interest, Fidelity & Blackrock own 35%. Its gonna fry the shorts. BUY IT!!!!
bought more XAIR and MTTR today as they were both down lots--XAIR down 20% and MTTR 8%. they're both about 30% off recent highs. that's probably about as much XAIR as i want to buy, but i'd buy a little more MTTR if it drops to 20.